Barbara Ann Karmanos Cancer Institute — Lansing, Michigan

Barbara Ann Karmanos Cancer Institute is a clinical research site located in Lansing, Michigan, United States 48912.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Barbara Ann Karmanos Cancer Institute has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Multiple Myeloma, Metastatic Castration-resistant Prostate Cancer.

Sponsors: AbbVie, Amgen.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Lansing

Browse all research sites in Michigan · View every site in Lansing

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Barbara Ann Karmanos Cancer Institute?

Barbara Ann Karmanos Cancer Institute has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Barbara Ann Karmanos Cancer Institute conducted?

Barbara Ann Karmanos Cancer Institute has 2 clinical trials on record, with 2 currently active. Their work covers Multiple Myeloma, Metastatic Castration-resistant Prostate Cancer.

Is Barbara Ann Karmanos Cancer Institute accredited by Crixeo Clinical Trials?

Barbara Ann Karmanos Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Barbara Ann Karmanos Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.